颈动脉内膜剥脱术中鱼精蛋白使用的获益与风险:更新系统综述与荟萃分析
鱼精蛋白显著降低任何颈部血肿(OR 0.49,95%CI 0.39-0.60;p<.001)及需再手术血肿(OR 0.48,95%CI 0.35-0.67;p<.001),与较低卒中率相关(OR 0.85,95%CI 0.74-0.97;p=.018),死亡率无差异(OR 0.95,95%CI 0.69-1.31;p=.77)。所有结局的GRADE证据确定性均为极低。
要点
- 鱼精蛋白显著降低颈部血肿及需再手术血肿风险。
- 鱼精蛋白与较低卒中率相关,死亡率无显著差异。
- 所有结局证据确定性极低,需进一步研究。
核心结论
- 鱼精蛋白可能降低颈动脉内膜剥脱术的风险而不增加不良结局,但现有证据确定性极低。
研究设计与样本
- 使用R Studio version 5.3进行统计分析,采用I2统计量评估异质性。
主要发现
- 鱼精蛋白显著降低任何颈部血肿发生率(OR 0.49,95%CI 0.39-0.60;p<.001)。
- 鱼精蛋白显著降低需再手术的颈部血肿发生率(OR 0.48,95%CI 0.35-0.67;p<.001)。
- 鱼精蛋白与较低卒中率相关(OR 0.85,95%CI 0.74-0.97;p=.018)。
- 鱼精蛋白与死亡率无显著差异(OR 0.95,95%CI 0.69-1.31;p=.77)。
- 所有分析结局的GRADE证据确定性评级为极低。
临床怎么用
- 在颈动脉内膜剥脱术中可考虑使用鱼精蛋白以减少颈部血肿及需再手术血肿,但需权衡极低确定性证据。
局限性
- 所有结局的GRADE证据确定性均为极低,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite all the advances in endovascular techniques, carotid endarterectomy (CEA) remains the standard intervention for carotid stenosis. The refinement of intra- and post-operative care increasingly aims to increasingly minimize the risks associated with this procedure, especially neurological and cardiovascular events. This study aimed to summarise the literature on the benefits and harms of protamine use during CEA. DATA SOURCES: PubMed (MEDLINE), Embase, and Cochrane databases. REVIEW METHODS: MEDLINE, Embase, and Cochrane databases were systematically searched for studies of patients undergoing CEA whose population was partially given protamine. Outcomes included cervical haematomas, stroke, myocardial infarction, and overall mortality rate. Statistical analysis was performed using R Studio version 5.3. Heterogeneity was assessed with the I2 statistic. RESULTS: Twelve studies, including over 87 000 CEAs, were analysed. Protamine administration significantly reduced the rate of any cervical haematoma (odds ratio [OR] 0.49, 95% confidence interval [CI] 0.39 - 0.60; p < .001) as well as haematomas requiring re-operation (OR 0.48, 95% CI 0.35 - 0.67; p < .001). There was an association with a lower stroke rate after protamine use (OR 0.85, 95% CI 0.74 - 0.97; p = .018). Finally, no difference was identified in terms of mortality (OR 0.95, 95% CI 0.69 - 1.31; p = .77). The GRADE certainty of evidence was rated as very low across all outcomes analysed. CONCLUSION: Protamine may reduce the risks of CEA without increasing adverse outcomes. However, further research is needed given the very low certainty of the available evidence.
引用
- Marcolin Miranda L, De Carvalho Dias Miranda N, Carneiro De Lima PE, et al. Editor's Choice - Benefits and Harms of Protamine Use during Carotid Endarterectomy: An Updated Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2026. PMID: 41997453. doi:10.1016/j.ejvs.2026.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。